Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
2373
mi
from 98109
Philadelphia, PA
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
949
mi
from 98109
Rapid City, SD
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
949
mi
from 98109
Rapid City, SD
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
1775
mi
from 98109
Austin, TX
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1775
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
1890
mi
from 98109
Houston, TX
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
1866
mi
from 98109
The Woodlands, TX
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1866
mi
from 98109
The Woodlands, TX
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
701
mi
from 98109
Salt Lake City, UT
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
2325
mi
from 98109
Burlington, VT
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2325
mi
from 98109
Burlington, VT
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
952
mi
from 98109
Encino, CA
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
952
mi
from 98109
Encino, CA
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
976
mi
from 98109
Fullerton, CA
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
976
mi
from 98109
Fullerton, CA
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
1049
mi
from 98109
La Jolla, CA
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1049
mi
from 98109
La Jolla, CA
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
2541
mi
from 98109
Altamonte Springs, FL
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2541
mi
from 98109
Altamonte Springs, FL
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
2616
mi
from 98109
Fort Myers, FL
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2616
mi
from 98109
Fort Myers, FL
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
2543
mi
from 98109
Lakeland, FL
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2543
mi
from 98109
Lakeland, FL
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
2513
mi
from 98109
Largo, FL
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2513
mi
from 98109
Largo, FL
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
2730
mi
from 98109
Miami, FL
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
2329
mi
from 98109
Tallahassee, FL
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2329
mi
from 98109
Tallahassee, FL
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
2164
mi
from 98109
Marietta, GA
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2164
mi
from 98109
Marietta, GA
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
1867
mi
from 98109
Indianapolis, IN
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1867
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
1523
mi
from 98109
Oklahoma City, OK
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1523
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
366
mi
from 98109
Medford, OR
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
366
mi
from 98109
Medford, OR
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
2313
mi
from 98109
Fairfax, VA
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2313
mi
from 98109
Fairfax, VA
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
229
mi
from 98109
Spokane, WA
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
229
mi
from 98109
Spokane, WA
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
1031
mi
from 98109
Oceanside, CA
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1031
mi
from 98109
Oceanside, CA
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
2182
mi
from 98109
Tucker, GA
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2182
mi
from 98109
Tucker, GA
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
885
mi
from 98109
Henderson, NV
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
885
mi
from 98109
Henderson, NV
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
1994
mi
from 98109
Harlingen, TX
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1994
mi
from 98109
Harlingen, TX
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
2161
mi
from 98109
Morgantown, WV
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2161
mi
from 98109
Morgantown, WV
Click here to add this to my saved trials
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated:  12/31/1969
mi
from 98109
Leipzig,
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
mi
from 98109
Leipzig,
Click here to add this to my saved trials
Family Studies of Eye Traits
Family Studies of Ocular Traits
Status: Enrolling
Updated:  12/31/1969
2326
mi
from 98109
Baltimore, MD
Family Studies of Eye Traits
Family Studies of Ocular Traits
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
2326
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Family Studies of Eye Traits
Family Studies of Ocular Traits
Status: Enrolling
Updated:  12/31/1969
2315
mi
from 98109
Bethesda, MD
Family Studies of Eye Traits
Family Studies of Ocular Traits
Status: Enrolling
Updated: 12/31/1969
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Family Studies of Eye Traits
Family Studies of Ocular Traits
Status: Enrolling
Updated:  12/31/1969
2485
mi
from 98109
Boston, MA
Family Studies of Eye Traits
Family Studies of Ocular Traits
Status: Enrolling
Updated: 12/31/1969
Boston University
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Family Studies of Eye Traits
Family Studies of Ocular Traits
Status: Enrolling
Updated:  12/31/1969
2024
mi
from 98109
Cleveland, OH
Family Studies of Eye Traits
Family Studies of Ocular Traits
Status: Enrolling
Updated: 12/31/1969
University Hospitals of Cleveland
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Family Studies of Eye Traits
Family Studies of Ocular Traits
Status: Enrolling
Updated:  12/31/1969
1616
mi
from 98109
Madison, WI
Family Studies of Eye Traits
Family Studies of Ocular Traits
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
1616
mi
from 98109
Madison, WI
Click here to add this to my saved trials
Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions
"Retrospective Study of Niacin (as a Vasodilator), Combined With a Topical Steroid (for Macular Edema), For CRVO, HRVO, BRVO."
Status: Enrolling
Updated:  12/31/1969
704
mi
from 98109
Palo Alto, CA
Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions
"Retrospective Study of Niacin (as a Vasodilator), Combined With a Topical Steroid (for Macular Edema), For CRVO, HRVO, BRVO."
Status: Enrolling
Updated: 12/31/1969
Palo Alto Medical Foundation Department of Ophthalmology
704
mi
from 98109
Palo Alto, CA
Click here to add this to my saved trials
AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Age-Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Status: Enrolling
Updated:  12/31/1969
2180
mi
from 98109
Atlanta, GA
AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Age-Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Status: Enrolling
Updated: 12/31/1969
Emory University Eye Center
2180
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Age-Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Status: Enrolling
Updated:  12/31/1969
2315
mi
from 98109
Bethesda, MD
AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Age-Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Status: Enrolling
Updated: 12/31/1969
National Eye Institute
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Age-Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Status: Enrolling
Updated:  12/31/1969
2341
mi
from 98109
Durham, NC
AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Age-Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Status: Enrolling
Updated: 12/31/1969
Duke University Eye Center
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Age-Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Status: Enrolling
Updated:  12/31/1969
146
mi
from 98109
Portland, OR
AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Age-Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Status: Enrolling
Updated: 12/31/1969
Devers Eye Center
146
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt
Status: Enrolling
Updated:  12/31/1969
977
mi
from 98109
Los Angeles, CA
Various
977
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Controlling Myopia Progression With Soft Contact Lenses (Contact Lens Control)
Controlling Myopia Progression With Soft Contact Lenses
Status: Enrolling
Updated:  12/31/1969
2485
mi
from 98109
Boston, MA
Controlling Myopia Progression With Soft Contact Lenses (Contact Lens Control)
Controlling Myopia Progression With Soft Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Myopia Progression After Ceasing Myopia Control Contact Lens Wear
Myopia Progression After Ceasing Myopia Control Contact Lens Wear
Status: Enrolling
Updated:  12/31/1969
2485
mi
from 98109
Boston, MA
Myopia Progression After Ceasing Myopia Control Contact Lens Wear
Myopia Progression After Ceasing Myopia Control Contact Lens Wear
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
A Comparison of Two Daily Disposable Soft Contact Lenses
Status: Enrolling
Updated:  12/31/1969
2154
mi
from 98109
Montgomery, AL
A Comparison of Two Daily Disposable Soft Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2154
mi
from 98109
Montgomery, AL
Click here to add this to my saved trials
A Comparison of Two Daily Disposable Soft Contact Lenses
Status: Enrolling
Updated:  12/31/1969
2466
mi
from 98109
Jacksonville Beach, FL
A Comparison of Two Daily Disposable Soft Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2466
mi
from 98109
Jacksonville Beach, FL
Click here to add this to my saved trials
A Comparison of Two Daily Disposable Soft Contact Lenses
Status: Enrolling
Updated:  12/31/1969
2541
mi
from 98109
Longwood, FL
A Comparison of Two Daily Disposable Soft Contact Lenses
Status: Enrolling
Updated: 12/31/1969
2541
mi
from 98109
Longwood, FL
Click here to add this to my saved trials
A Comparison of Two Daily Disposable Soft Contact Lenses
Status: Enrolling
Updated:  12/31/1969
2545
mi
from 98109
Winter Park, FL
A Comparison of Two Daily Disposable Soft Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2545
mi
from 98109
Winter Park, FL
Click here to add this to my saved trials
A Comparison of Two Daily Disposable Soft Contact Lenses
Status: Enrolling
Updated:  12/31/1969
2006
mi
from 98109
Westerville, OH
A Comparison of Two Daily Disposable Soft Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2006
mi
from 98109
Westerville, OH
Click here to add this to my saved trials
A Comparison of Two Daily Disposable Soft Contact Lenses
Status: Enrolling
Updated:  12/31/1969
2238
mi
from 98109
Salem, VA
A Comparison of Two Daily Disposable Soft Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2238
mi
from 98109
Salem, VA
Click here to add this to my saved trials
Does Using a Low Vision Aid Device Improve Quality of Life in Glaucoma Patients?
The Impact of a Novel Artificial Vision Device (OrCam) on the Quality of Life of Patients With Advanced Glaucoma
Status: Enrolling
Updated:  12/31/1969
2373
mi
from 98109
Philadelphia, PA
Does Using a Low Vision Aid Device Improve Quality of Life in Glaucoma Patients?
The Impact of a Novel Artificial Vision Device (OrCam) on the Quality of Life of Patients With Advanced Glaucoma
Status: Enrolling
Updated: 12/31/1969
Wills Eye Hospital
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert
An Open-label Extension (OLE 2) Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert in Subjects With Open-angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-004
Status: Enrolling
Updated:  12/31/1969
976
mi
from 98109
Artesia, CA
An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert
An Open-label Extension (OLE 2) Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert in Subjects With Open-angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-004
Status: Enrolling
Updated: 12/31/1969
Sall Medical Research Center
976
mi
from 98109
Artesia, CA
Click here to add this to my saved trials
An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert
An Open-label Extension (OLE 2) Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert in Subjects With Open-angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-004
Status: Enrolling
Updated:  12/31/1969
1643
mi
from 98109
Fayetteville, AR
An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert
An Open-label Extension (OLE 2) Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert in Subjects With Open-angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-004
Status: Enrolling
Updated: 12/31/1969
Vold Vision, PLLC
1643
mi
from 98109
Fayetteville, AR
Click here to add this to my saved trials